Changes in patient recruitment parameters and their derivatives under the influence of external factors – population size and density of residence in a certain area

Author:

Milovanov S. S.1ORCID

Affiliation:

1. IP Milovanov Svyatoslav Sergeevich

Abstract

Background. The lack of targeted patient recruitment for clinical trials reaches 90%, which leads to failures of a trial as a whole and insufficient access to the necessary treatment or diagnostic method for patients. To find out the reasons for recruitment failures, many factors are considered, the action of which is difficult to assess due to high variability. In general, various factors are named that reduce patient recruitment, while factors that improve it are much less known.Objective: to investigate changes in the parameters and indicators of patient recruitment for clinical trials depending on the influence of external factors.Material and methods. A retrospective analysis of four international multicenter clinical trials of phases II–III was performed by 16 patient recruitment parameters and their 6 derivatives (indicators) – both widely used in the literature and newly proposed. A total of 622 patients from 70 clinical centers located in 59 cities of Russia, Ukraine, and Belarus were included in the study. The methods of descriptive statistics and typing were used. To study the influence of factors, internal and external factors were selected, external factors including population size, area and density of residence were analysed, and changes in parameters and indicators depending on the influence of each factor were examined. The area and population density were studied in inseparable connection with each other.Results. A simple classification of factors was proposed – external and internal to the clinical center where patients were recruited. The factors classified as external were analyzed depending on the change in the proposed parameters of patient recruitment for clinical trials and their relationships – indicators (derivatives). The final rate of patient recruitment and the final number of patients recruited in the population group of 1–2 million people had statistically significant (p<0.05) higher values (0.57±0.20 and 15.08±5.06, respectively) than in group with up to 1 million people – 0.14±0.05 and 3.75±1.24.Conclusion. For the first time, an extended panel of parameters and indicators that allow evaluating the influence of various factors on patient recruitment for clinical trials was proposed. The value of the proportion of parameters and indicators that had statistical differences among themselves in the group influenced by the population size factor was more than twice as large as the proportion of similar parameters and indicators in the group influenced by area and population density: 47% and 23%, respectively, which may indicate more strong influence of the first factor.

Publisher

IRBIS

Reference18 articles.

1. GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022; 400 (10352): 563–91. https://doi.org/10.1016/S0140-6736(22)01438-6.

2. Berenson A. Big drug makers see sales decline with their image. The New York Times (Nov. 14, 2005). Available at: https://www.nytimes.com/2005/11/14/business/big-drug-makers-see-sales-decline-withtheir-image.html (accessed 28.07.2023).

3. Hawthorne F. How big pharma blew it: bad choices and PR gaffes have finally caught up with the drug industry. The Free Library. Available at: https://www.thefreelibrary.com/How+Big+Pharma+blew+it%3a+bad+choices+and+PR+gaffes+have+finally+caught...-a0126397385 (accessed 28.07.2023).

4. Kumar N., Crocker T., Smith T., et al. Challenges and potential solutions to meeting accrual goals in a phase II chemoprevention trial for prostate cancer. Contemp Clin Trials. 2012; 33 (2): 279–85. https://doi.org/10.1016/J.CCT.2011.11.004.

5. Nguyen T.T., Jayadeva V., Cizza G., et al. Challenging recruitment of youth with type 2 diabetes into clinical trials. J Adolesc Health. 2014: 54 (3): 247–54. https://doi.org/10.1016/j.jadohealth.2013.08.017.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3